Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2005
07/28/2005US20050164313 Methods and compositions for the detection of cervical cancer
07/28/2005US20050164311 Biological assay detection method
07/28/2005US20050164310 Using voltage sensitive dyes to identifying modulators of G-protein sensory signaling; immunoassay; customizing taste of foods and/or medicines
07/28/2005US20050164306 Methods for screening for a compound useful in the treatment or prevention of lymphocytic disorders, for inhibiting lymphocite activity and preventing or treating lymphocytic disorders
07/28/2005US20050164305 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1)
07/28/2005US20050164299 Phase change sensor
07/28/2005US20050164298 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor(ghs)
07/28/2005US20050164293 Using microarrays comprising immobilized receptors to detect preferential nucleotide sequences; gene expression analysis; identifying polymorphisms in genomic sequences; preparing antisense nucleotides; diagnosing genetic disorders
07/28/2005US20050164291 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
07/28/2005US20050164290 Computer generated nucleic acid probe arrays
07/28/2005US20050164289 Using self assembled surface comprising conjugated gold-alkanethiol molecules for monitoring DNA hybridization
07/28/2005US20050164287 Nucleic acid ladders
07/28/2005US20050164286 Nucleic acid concentration quantitative analysis chip, nucleic acid concentration quantitative analysis apparatus, and nucleic acid concentration quantitative analysis method
07/28/2005US20050164284 Immunoglobulin composition for detection of cell death regulatory proteins; diagnosing cardiovascular, tumor, diabetic and nervous system disorders
07/28/2005US20050164283 Mesoporous permeation layers for use on active electronic matrix devices
07/28/2005US20050164282 Synthetic cell-or tissue-specific transcriptional regulatory regions
07/28/2005US20050164279 Secreted and transmembrane polypetides and nucleic acids encoding the same
07/28/2005US20050164278 Breast cancer specific genes (BSG) and diagnosing/preventing cell proliferative disorders; immunotherapy; paramagnetic imaging
07/28/2005US20050164276 Nucleotide sequences coding serine protease like polypeptides for use in diagnosis and treatment of infection, diabetes, obesity and infertility
07/28/2005US20050164275 Phosphodiesterases
07/28/2005US20050164273 Using weighted color ratio to accurately determine gene expression patterns; bioinformatics; computer programs
07/28/2005US20050164272 Using transcriptional variance in matched samples as tool in identifying/diagnosing endometrial adenocarcinoma
07/28/2005US20050164271 Antisense agents for treatment of adrenocorticotropic hormone dysregulation; gene expression inhibition; antidiabetic agents; anticholesterol agents; antilipemic agents
07/28/2005US20050164270 Methods and system for providing a polymorphism database
07/28/2005US20050164268 Oncology diagnosis; gene overexpression/underexpression; tumor suppressor genes
07/28/2005US20050164267 Using caudal-1 gene (CDX-1) as diagnostic indicator of stomach or esophageal cancer; immunodiagnostics
07/28/2005US20050164266 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/28/2005US20050164264 Determining amino acid sequence of protein via directed release of preferential amino acids into solution; direct protein evolution
07/28/2005US20050164263 identification of amino acid sequences and proteins related to MAP/ERK subfamily; gene chip; transgenic nonhuman animal; nucleic acid vector; expression in larynx epithelium, Wilms' tumors of the kidney, pancreas adenocarcinomas, fetal brain, and hippocampus; models for human therapeutic targets
07/28/2005US20050164262 Salmonella specific nucleotide probe; microorganismal detection; food safety and quality control
07/28/2005US20050164261 Multiplexed analysis of clinical specimens apparatus and methods
07/28/2005US20050164260 Using lysozyme, ribonuclease, metal chelators and non-ionic detergents to isolate organismal nucleic acid sequences; DNA extraction
07/28/2005US20050164258 Solid phase combinatorial synthesis; deprotecting via acid generator
07/28/2005US20050164255 solid phase synthesis using a mixture of nucleotides and nucleotide analogs, and a supported target DNA and DNA polymerase; template directed extension of a primer; spectrum analysis
07/28/2005US20050164254 Compositions and their uses directed to metabolic proteins
07/28/2005US20050164253 Using blood lymphocyte DNA as diagnostic tool in detection of autoimmune disease
07/28/2005US20050164252 Methods using non-genic sequences for the detection, modification and treatment of any disease or improvement of functions of a cell
07/28/2005US20050164250 Compositions and methods for the diagnosis and treatment of tumor
07/28/2005US20050164249 Solid support comprising a plurality of immobilized, positionally distinguishable, multi-subunit sequence specific reagents for use in characterization and classification of biological samples; immunoaffinity chromatography
07/28/2005US20050164247 isolated nucleic acid molecule wherein CD4+T cells over-expressing said nucleic acid sequence exhibits a reduction in CD3 and CD28 mediated T-cell proliferation; vector and host cell transformed with said nucleic acid
07/28/2005US20050164246 Methods and compositions for diagnosing lung cancer with specific DNA methylation patterns
07/28/2005US20050164244 Methods of determining juvenile arthritis classification
07/28/2005US20050164243 Nucleic acid probes and methods for detecting clinically important fungal pathogens
07/28/2005US20050164241 Cell-free blood serum/plasma from pregnant woman for use in detection of rhesus antigen D (RHD) and diagnosis of hemolytic disease of fetus and/or newborn
07/28/2005US20050164240 Eucaryotic transcription factor antisense nucleotides for detection and treatment of cancer; antitumor agents
07/28/2005US20050164239 Optical sorting method
07/28/2005US20050164238 Methods and compositions for the diagnosis of sepsis
07/28/2005US20050164236 Device and method of detecting mutations and polymorphisms in DNA
07/28/2005US20050164235 Modified iRNA agents
07/28/2005US20050164234 Antisense therapy; gene expression inhibition
07/28/2005US20050164233 Compositions, kits and methods for identification and modulation of type I diabetes
07/28/2005US20050164232 Reg-like protein
07/28/2005US20050164231 Probe composition for modeling prognostic outcomes for cell proliferative disorders; computer models for disease
07/28/2005US20050164230 Assays for the detection of microtubule depolymerization inhibitors
07/28/2005US20050164229 Using chromosomal insertion-deletion marker specific primers for thermal dependent DNA amplification/replication; diagnosing cell proliferative disorders of urogenital system
07/28/2005US20050164228 Compositions and methods for detecting and treating neurological conditions
07/28/2005US20050164226 RNA detection and quantitation
07/28/2005US20050164225 Bis-diazo,triaryl and aryldiazo-N-arylphenazonium moieties; labels for polynucleotides, nucleosides, nucleotides, and polypeptides; fluorescence resonance energy transfer
07/28/2005US20050164223 Specific method of prostate cancer detection based on PCA3 gene and kits therefor
07/28/2005US20050164220 Using phosphodiesterase haplotype as diagnostic tool in detection cerebral cardiovascular ischemic events; antiischemic agents; microsatellite markers and stroke prognosis
07/28/2005US20050164219 Diagnostic probe comprising template and target binding regions for use in polymerase chain reaction amplification
07/28/2005US20050164218 Using growth factor expression as diagnostic indicator of human receptivity to suppression via epidermal growth factor inhibitory compounds; antitumlor agents; anticarcinogenic agents
07/28/2005US20050164216 Methods and compositions for selectively cleaving DNA containing duplex nucleic acids in a complex nucleic acid mixture, and nuclease compositions for use in practicing the same
07/28/2005US20050164215 Methods for rapid purification of nucleic acids for subsquent analysis by mass spectrometery by solution capture
07/28/2005US20050164214 Methods for protein interaction determination
07/28/2005US20050164213 Replicating nucleotide sequences without the need for exogenously-added oligonucleotide primers or terminal protein covalently bound to either 5' end; polymerase replication
07/28/2005US20050164212 Modulation of gene expression using DNA-RNA hybrids
07/28/2005US20050164211 Carbon nanotube molecular labels
07/28/2005US20050164210 Regulated polymerase III expression systems and related methods
07/28/2005US20050164209 Using phenotypic variance to identify bioactive oligomers; gene expression analysis; RNA interference;
07/28/2005US20050164208 Storage of genetic information
07/28/2005US20050164207 Method of oligonucleotide synthesis
07/28/2005US20050164206 For use in gene therapy
07/28/2005US20050164205 Using light scattering and electrophoresis to detect molecules, molecular interactions or molecular complexes; for counting, differentiating and identifying molecules via direct detection of interaction with one or more probes that contain charge, mass or charge and mass tags
07/28/2005US20050164204 Single use lyophilized rnase reagents, and kits and methods for using same
07/28/2005US20050164203 analyzing genomic DNA to determine the presence of repeat sequences and comparing them with corresponding repeat sequences of putative ancestors, to determine the lineage of an individual
07/28/2005US20050164201 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses therof
07/28/2005US20050164200 Method for detecting biochemical reactant biochip
07/28/2005US20050164199 Method for biochemical analysis of dna and arrangement associated therewith
07/28/2005US20050164198 Mutant sequence analyzer
07/28/2005US20050164196 Using allelic variation in interleukin expression as diagnostic tool in prediciting human response to imatinib mesylate; enzyme inhibitors and cancer treatment; immunodiagnostics
07/28/2005US20050164194 Growth regulating proteins
07/28/2005US20050164193 Using matrix assisted laser desorption to monitor cytosine methylation; gene epression inhibition; diagnosing cell proliferative disorders; genomics
07/28/2005US20050164190 Primers for nucleic acid amplification in detecting housekeeping gene mrna and test method using these primers
07/28/2005US20050164189 Molecular diagnosis and prognosis of carcinomas
07/28/2005US20050164188 Analysis device
07/28/2005US20050164187 Simulating microarrays using a parameterized model
07/28/2005US20050164186 Analyzing and determining in a population prokaryotic host cells having gene expression for modualtion methyltransferases, whether viable cells express an active mutant hydrolase enzymes; genetic engineering
07/28/2005US20050164184 Hybridization portion control oligonucleotide and its uses
07/28/2005US20050164182 Nucleoside comprising reporter molecule cleavable by hydrolase such as esterases, phosphatases, peptidases, penicillin amidases, glycosidases, and phosphorylases; limits polymerase activity; sequencing; solid phase synthesis
07/28/2005US20050164181 Multicompartment, transparent , microchannel apparatus comprised of plastic, silicon, glass, metal oxide or composite carrier for use in single molecule analysis; sequence determination of polynucleotides
07/28/2005US20050164178 Starch branching enzyme
07/28/2005US20050164177 Reactions on a solid surface
07/28/2005US20050164174 Identifying non-human primate genomic sequences associated with enhanced protection from viral infection viral; enhancing resistance to hepatitis associated viral infections
07/28/2005US20050164172 Modulation of HSV infection
07/28/2005US20050164171 High-throughput assay for virus entry and drug screening
07/28/2005US20050164170 Neurovirulent strain of the west nile virus and uses thereof
07/28/2005US20050164169 Using protein-nanoparticle fusions as diagnostic tools in detection of preferential particles on surfaces; nanotechnology and environmental cleanup, sanitization and quality of human health
07/28/2005US20050164168 Using fluorescent peptide fragment of interferon-gamma as diagnostic tool in determining mycobacterium infection; competitive binding
07/28/2005US20050164167 Using subgenomic viral replication system to monitor efficacy of viricidal agents; drug screening and design; viricides